Mucommune LLC
Durham, NC
- UEI
- NWVPL2L4JMN8
- CAGE
- 7C3Q6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Sole Proprietorship
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1106 Crested Jay Dr, Durham, NC 27707, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir: in vivo engineering of multifaceted B7H3.car-t cells for cellular immunotherapy of pancreatic ductal… | National Cancer Institute | $3,439,319 | |
| Development and evaluation of a pegloticase biobetter for sustained suppressionof fructose-induced obesity - project… | National Institute of Diabetes and Digestive and Kidney Diseases | $719,216 | |
| Fast dissolving MM008 tablet for instant on-demand non-hormonal contraception - project summary nearly half of all… | National Institute of Child Health and Human Development | $1,130,880 | |
| Development of MM010, a peg-specific intervention that blocks allergic response and restores effective repeat dosing… | National Cancer Institute | $819,464 | |
| Sbir: in vivo engineering of B7-H3.car-t cells for ovarian cancer therapy - project summary t-cells modified with… | National Cancer Institute | $2,057,385 |
About Mucommune LLC
Mucommune LLC is a biopharmaceutical company based in Durham, North Carolina, specializing in innovative medical technologies across reproductive health, infectious disease prevention, and targeted antibody therapies. The company is a small, for-profit limited liability company registered in SAM.gov, focusing on developing advanced biotechnological solutions for complex medical challenges. Through federal contract and grant awards, Mucommune demonstrates expertise in developing cutting-edge medical interventions, particularly in areas involving monoclonal antibodies, intravaginal delivery systems, and novel therapeutic approaches.
Regarding federal contract awards, Mucommune LLC has secured a significant contract from the National Institute of Allergy and Infectious Diseases (NIAID) under the Small Business Innovation Research (SBIR) program. The $2,355,605 Firm Fixed Price contract focuses on developing a sustained release mechanism for VRC07 from a capsule-intravaginal ring to prevent HIV transmission. The contract is set aside for small businesses and has a performance period through June 30, 2028, highlighting the company's specialized research capabilities in developing targeted intervention strategies for infectious diseases.
In federal grant awards, Mucommune has received multiple project grants from various National Institutes of Health agencies, focusing on innovative medical research. These grants include developing in vivo-engineered CAR-T cells for cancer immunotherapy from the National Cancer Institute, creating non-hormonal contraceptive products from the National Institute of Child Health and Human Development, and designing interventions for conditions like bacterial vaginosis from the National Institute of Allergy and Infectious Diseases. The grants range from $310,136 to $1,146,618 and cover research areas such as cellular immunotherapy for pancreatic and ovarian cancers, anti-sperm antibody-based contraception, lactic acid-releasing intravaginal rings, and addressing challenges with pegylated drug therapies. Each grant demonstrates the company's commitment to developing sophisticated, targeted medical solutions across multiple therapeutic domains.
Quick answers
What is Mucommune LLC's UEI?
Mucommune LLC's Unique Entity ID (UEI) in SAM.gov is NWVPL2L4JMN8.
What is Mucommune LLC's CAGE code?
Mucommune LLC's CAGE code is 7C3Q6.
What is Mucommune LLC's primary NAICS code?
Mucommune LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Mucommune LLC located?
Mucommune LLC's physical address in SAM.gov is 1106 Crested Jay Dr, Durham, NC 27707, USA.
Is Mucommune LLC registered in SAM.gov?
Yes. Mucommune LLC's SAM.gov registration is active through July 25, 2027.
What is Mucommune LLC's most recent federal award?
Mucommune LLC's most recent federal grant award is Sbir: in vivo engineering of multifaceted B7H3.car-t cells for cellular immunotherapy of pancreatic ductal… (R44CA310402), from National Cancer Institute, on September 16, 2025.
On GovTribe
See Mucommune LLC's full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors